Larimar Therapeutics, Inc.

LRMR · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$90,140$20,587$21,126$33,218
Short-Term Investments$85,295$117,937$136,400$150,236
Receivables$0$983$1,056$1,054
Inventory$0$0$0$0
Other Curr. Assets$7,788$6,049$6,903$10,796
Total Curr. Assets$183,223$145,556$165,485$195,304
Property Plant & Equip (Net)$2,979$3,265$3,502$3,719
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,148$1,167$1,188$1,202
Total NC Assets$4,127$4,432$4,690$4,921
Other Assets$0$0$0$0
Total Assets$187,350$149,988$170,175$200,225
Liabilities
Payables$11,100$4,169$2,274$2,424
Short-Term Debt$1,151$1,129$1,096$1,060
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$32,865$21,351$18,764$20,872
Total Curr. Liab.$45,116$26,649$22,134$24,356
LT Debt$3,196$3,485$3,770$4,057
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$3,196$3,485$3,770$4,057
Other Liabilities$0$0$0$0
Cap. Leases$4,347$4,614$4,866$5,117
Total Liabilities$48,312$30,134$25,904$28,413
Equity
Pref Stock$0$0$0$0
Common Stock$86$64$64$64
Retained Earnings-$372,333-$324,621-$298,439-$269,158
AOCI$66-$9$54$148
Other Equity$511,219$444,420$442,592$440,758
Total Equity$139,038$119,854$144,271$171,812
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$187,350$149,988$170,175$200,225
Net Debt-$85,793-$15,973-$16,260-$28,101
Larimar Therapeutics, Inc. (LRMR) Financial Statements & Key Stats | AlphaPilot